Transition between the low- and high-density amorphous H2O was observed with a piston-cylinder apparatus from 77 K to 140 K, almost the glass-transition temperature of the amorphs. The transition was found to occur reversibly and abruptly at ∼135 K and ∼0.2 GPa with a volume change of 0.20±∼0.01 cm3/g and some hysteresis. This confirmed the transition to be first order. Absence of intermediate amorphous states between the low-density and high-density amorphs suggested existence of two substantially different liquid phases near the glass-transition temperature.
The volume of water (H(2)O) was obtained at about 200-275 K and 40-400 MPa by using emulsified water. The plot of volume against temperature showed slightly concave-downward curvature at pressures higher than ≈200 MPa. This is compatible with the liquid-liquid critical-point hypothesis, but hardly with the singularity-free scenario. When the critical point is assumed to exist at ≈50 MPa and ≈223 K, the experimental volume and the derived compressibility are qualitatively described by the modified Fuentevilla-Anisimov scaling equation.
According to the liquid-liquid critical-point hypothesis about water, two liquid waters exist at low temperatures and are supposed to be merged at a critical point. The low-temperature metastable melting curves of D2O ices have been measured. It is found that the melting curve of D2O ice III is smoothly curved around 25 MPa and 238 K, whereas the melting curve of D2O ice IV undergoes an abrupt change of slope at 100 MPa and 220 K. This is consistent with the existence of a liquid-liquid critical point in the region between the melting curve of D2O ice III and the melting curve of D2O ice IV.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.